Clinical Trial Update: Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis [Phase 1, Phase 2]

View source ↗

Summary

This document reports updated results from a Phase 1/Phase 2 trial evaluating a long-course Miltefosine regimen for Bolivian mucosal leishmaniasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: AB Foundation | Conditions: Leishmaniasis | Phase 1, Phase 2 | Status: COMPLETED